1. The pathogenesis of the mental retardation in phenylketonuria remains obscure. Leucocytes have proved of value in the study of other inborn errors of metabolism. The lymphocyte is a suitable model cell for the study of mammalian metabolism, because of its ability to divide in vitro in response to various stimuli.
Introduction
The pathogenesis of the mental retardation associated with phenylketonuria remains uncertain. Absence of hepatic phenylalanine hydroxylase activity in this inherited disease is responsible for the increase in the plasma phenylalanine concentration and in the production of abnormal amounts of phenylpyruvate, phenyl-lactate, o-hydroxyphenylacetate and phenylacetate. The clinical consequences of the metabolic lesion may be largely offset by the introduction of a diet low in phenylalanine in the first months of life.
Numerous biochemical changes have been reported in phenylketonuria, experimental hyperphenylalaninaemia and in models in vitro. The brains of phenylketonuric patients contain less than normal amounts of myelin (Shah, Peterson & McKean, 1972a) . Experimentally induced hyperphenylalaninaemia in animals has been shown to reduce both protein (Agrawal, Bone & Davison, 1970) Barbato, Barbato & Hamanaka, 1968) in the brain and a reduced amount of myelin (Shah, Peterson & McKean, 1972b) has been demonstrated in the brains of such animals. Phenylalanine or its metabolites inhibit enzymes concerned with glycolysis (Weber, Glazer & Ross, 1970) , pyruvate metabolism (Patel, 1972) and acetyl group metabolism (Land & Clark, 1973 ) in brain tissue in vitro.
The vulnerability of the postnatal brain-growth spurt is now well recognized (Dobbing, 1974) . The major events occupying this period are cell multiplication (mainly of glial cells), synaptogenesis and myelination. There is little information on the effects of phenylalanine and its metabolites on tissues other than brain. We considered it of interest to investigate the effect of these compounds on the metabolism of leucocytes and lymphocytes since these cells are a readily obtainable human tissue. The lymphocyte holds promise as a model cell for the study of mammalian metabolism in dividing tissue cells because it can undergo mitosis in vitro in response to various stimuli, including phytohaemagglutinin (Knight, Ling, Sell & Oxnard, 1965) . Stimulation activates the various cellular processes required to raise the cell from a resting to a mitotic state (Soren, 1973) .
In a general metabolic sense, the stimulated lymphocyte might resemble the actively growing brain. For the experiments reported here, human leucocytes and lymphocytes from rabbit mesenteric lymph nodes were used. The effect of phenylalanine and its metabolites upon the incorporation of radiochemical precursors into lipid, protein, ribonucleic acid (RNA) and deoxyribonucleic (DNA), and upon the activity of pyruvate kinase and citrate synthetase are reported. These enzymes in the brain have been reported to be inhibited by phenylalanine (Weber, 1969) and phenylpyruvate (Land & Clark, 1973) respectively. The results are compared with published data concerning the effects of these compounds on brain metabolism.
Methods

Materials
Purified phytohaemagglutinin was obtained from Wellcome Reagents Ltd, Beckenham, Kent, U.K. Medium RPMl 1640 buffered with 2-(N-2-hydroxyethylpiperazin-N'-y1)ethanesulphonic acid (Hepes buffer) and NaHC03 was from Bio-Cult Laboratories, Glasgow, Scotland; medium 199 and calf serum were from Flow Laboratories, Irving, Scotland. Sodium [l-14C] [U-14C] glucose (4 mCi/mmol) were obtained from The Radiochemical Centre, Amersham, Bucks., U.K. In the incorporation experiments the specific radioactivity of the radiochemical precursors was as purchased. Tracer amounts were used to ensure sufficiently high radioactivity in trichloroacetic acid-insoluble material. This was particularly necessary in the lipid study when the distribution of radioactivity amongst the lipid classes was to be determined. L-Phenyl-lactic acid was from Calbiochem, London. Other biochemicals and enzymes were obtained either from Sigma Chemical Co. or The Boehringer Corp. Ltd, London.
Unless otherwise stated, radioactivity was determined in 10 ml of scintillation fluid prepared from 2,5-diphenyloxazole (22-6 mmol/l) and 1 ,Chis-(5-phenyloxazol-2-y1)benzene (0.82 mmol/l), either a Unilux I1 (Nuclear-Chicago) or Tri-Carb (Packard) liquid-scintillation spectrometer being used. Corrections for quenching were made from derived standard curves.
Isolation and incubation of lymphocytes from rabbit mesenteric lymph nodes New Zealand white rabbits were killed by cervical fracture and the mesenteric lymph nodes excised. Adherent connective tissue was removed and the nodes were cut into small pieces and dispersed in about 20 ml of medium 199 containing Tris (2 mmol/l), NaHCO3 (4.2 mmol/l), penicillin (lo5 i.u./l) and streptomycin (100 mg/l), pH 7.4, by gentle maceration in a Tenbroek tissue grinder with a loosely fitting pestle. The cell suspension was filtered through muslin and incubated on a column (57 cmx1.3 cm) of polystyrene beads (Polybond 21 69, Jencons Scientific Ltd, Heme1 Hempstead, Herts., U.K.) at 37°C for 30 min to remove phagocytes. The cells were eluted from the column with 70-80 ml of medium, assessed for viability (Trypan Blue exclusion), counted (Improved Neubauer counting chamber) and harvested by centrifugation at 750 g for 10 min at 20°C. Cell yield varied between 800 and 1 5 0 0~1 0~ lymphocytes with a viability greater than 99 %. Lymphocytes were re-suspended (10-20 x 106/ml) in medium 1640 containing antibiotics and glutamine (2 mmol/l), pH 7.4. For incubations up to 12 h, heparin (3 x lo4 i.u./l) was added, and for longer incubations the medium was supplemented with 15% calf serum. When required, phytohaemagglutinin was added to a final concentration of 10 mg/l. Cultures (0.5 ml) in sterile polystyrene test tubes (Sterilin Ltd, Richmond, Surrey, U.K.) were incubated with phytohaemagglutinin for 4 h before the addition of an equal volume of phenylalanine, phenylpyruvate, phenyl-lactate or phenylacetate as 20 mmol/l solutions in medium. Incubations were performed in a shaking water bath at 37°C in an atmosphere of air. Radiochemical precursors (1 pCi, 0.1 ml) were generally added for the last 4 h of the incubation. Cells were harvested by centrifugation and extracted with trichloroacetic acid (0.6 mol/l, 3 x 5 ml).
Zsolation of human Ieucocytes
Leucocytes were isolated by a modification of the method of Pidduck, Keenan & Price Evans (1971) . To 2 ml of venous blood, anticoagulated with ethylenediaminetetra-acetate (EDTA), was added 1 ml of 30 g/l Dextran (grade A, BDH Chemicals Ltd, Poole, Dorset, U.K.) in 150 mmol/l NaCl and after thorough mixing the cell suspension was allowed to sediment for l h at 37°C. The leucocyterich supernatant was aspirated and centrifuged at 4°C for 8 min at 200 g. The cell pellet was washed by suspension and centrifugation in 1 ml of 20 g/1 bovine serum albumin in 150 mmol/l NaCl. After harvesting and washing in 1 ml of albumin-EDTA solution, the cells were suspended in 1 ml of 50 mmol/l ammonium oxalate in 75 mmol/l NaCl, centrifuged and suspended in 10 ml of albumin-EDTA solution, counted and assessed for viability. The yield by this method was generally 2 . 9 4 1 x lo6 leucocytes from 2 ml of blood. The preparation was essentially lymphocyte-free with a viability of greater than 99%.
Incubation of human Ieucocytes
Acetate-incorporation studies. In preliminary experiments human leucocytes, isolated as described above, were incubated with [l-14C]acetate in a variety of media at pH 7.4: (1) Krebs-RingerNaHC03 containing albumin (40 g/l); (2) isotonic phosphate buffer (66 mmol/l KH2P04, 77 mmol/l NaCI) containing EDTA (2.7 mmol/l) and albumin (40 g/I); (3) Gey buffer (Gey & Gey, 1936) . These experiments gave extremely variable results, largely because of the cells 'clumping' during the 3 h incubation period. The following procedure was therefore adopted: to 1.7 ml of venous blood (anticoagulated with EDTA) was added [1-14C] acetate (2 pCi) and either phenylalanine or its metabolites to give a final concentration of 10 mmol/l in an incubation volume of 2 ml. Incubations were performed in a shaking water bath at 37°C in an atmosphere of air. After 3 h leucocytes were isolated as described above, counted and assessed for viability. Cells were harvested by centrifugation and extracted with trichloroacetic acid (0.6 mol/l, 3 x 5 ml).
Glucose-incorporation studies. [U-' 4C]Glucose incorporation into leucocyte lipid was studied in isolated cells suspended in the isotonic phosphate buffer. 'Clumping' was not a problem in these experiments because of the shorter incubation period. Leucocytes were suspended at a density of about lo7 cells/ml and 0.5 ml aliquots were made up to 1 ml with [U-14C]glucose (1 pCi, 0.1 ml) and the compounds under test dissolved in buffer (25 mmol/l, 0.4 ml). Plastic bottles (20 ml) fitted with Subaseal stoppers were used for the incubations. The stoppers held a small glass well suspended inside the bottle. At the end of a 1 h incubation in a shaking water bath at 37"C, 0.5 ml of Hyamine (1 mol/l in methanol) was injected into the glass well and 0.5 ml of 1 mol/l was injected into the cell suspension. After a further incubation of 1 h, the radioactivity of the I4CO2 trapped in the Hyamine was determined. The cell suspension was transferred to a centrifuge tube and extracted with trichloroacetic acid (0.6 mol/l, 3 x 5 ml). Under these conditions, incorporation of [14C]glucose into lipid and ' T O 2 production was linear for at least 1.5 h.
Thin-layer chromatography and scintillation counting
Radioactivity of protein, RNA and DNA in trichloroacetic acid-insoluble material was measured by dissolving the pellet in 1 ml of 19 mol/l formic acid, transferring 0.5 ml to a scintillation vial and adding 10 ml of scintillation fluid containing 33% (v/v) Triton X-100. Lipid was extracted from trichloroacetic acid-insoluble material by the method of Garbus, Deluca, Loomans & Strong (1963) and finally dissolved in 1 ml of propan-2-01-light petroleum (b.p. 4040°C) ( l : l , v/v); 0.5 ml was transferred to a scintillation vial, evaporated to dryness and 10 ml of scintillation fluid added.
The lipid extract was fractionated into its major components by thin-layer chromatography on silica gel with double-development in one dimension : first solvent (10 cm rise) di-isopropyl ether-acetic acid (96:4, v/v); second solvent (20 cm rise) light petroleum (b.p. 40-6O0C)-diethyl ether-acetic acid (90: 10: 1, by vol.). The fractions were visualized by using iodine vapour and ultraviolet light. When the iodine had evaporated, the fractions were scraped off into scintillation vials, scintillation fluid was added and the radioactivity determined.
Enzyme assays
Rabbit lymphocytes, isolated as described above, were homogenized as previously reported (Parkes & Bradley, 1974) . A mitochondrial pellet was prepared by centrifuging a 10000 g-min supernatant at 4°C for 125 000 g-min. The pellet was washed by resuspension in the original volume of buffer (148 mmol/l NaCI-2 mmol/l Tris, pH 7.4) and centrifugation. The mitochondria1 preparation was finally suspended in one-third the original volume of NaCITris buffer. A high-speed supernatant was prepared by centrifuging the post-mitochondria1 fraction at 4°C for 30 min at 105 000 g. Enzyme activities were determined at 30°C. Data for Lineweaver-Burk and Dixon plots were subjected to regression analysis to reveal the best-fit straight line. Pyruvate kinase (EC 2.7.1.40) activity was measured by the method of Bucher & Pfleiderer (1955) . The reaction mixture contained 50 pmol of Tris, pH 7.4, 0.3 pmol of NADH, 2 pmol of ADP, 3 pmol of phosphoenolpyruvate, 75 pmol of KCI, 8 pmol of MgS04, 10 pg of lactate dehydrogenase and approximately 3 pg of high-speed supernatant protein in a final volume of 1 ml. Citrate synthetase (EC 4.1.3.7) activity was determined in mitochrondrial preparations that had been frozen and thawed three times. The assay was essentially that of Coore, Denton, Martin & Randle (1971) . The reaction mixture contained 40 pmol of triethanolamine, 
Statistical methods
was assessed with Student's t-test.
The significance of differences between mean values
Results
Leucocyte experiments
[1-l4C]Acetate and [U-14C]glucose were incorporated predominantly into the polar lipid and triglyceride fractions of human leucocyte lipid (Tables 1 and  2 ). The distribution of radioactivity with both precursors is in general agreement with published data (Malamos, Miras, Levis & Mantzos, 1962; Miras, Legakis & Levis, 1967) . Acetate incorporation was inhibited in the presence of 10 mmol/l phenyl-lactate and phenylpyruvate by 48 % and 38 % respectively (Table 1 ). The distribution of radioactivity amongst the major lipid fractions (Table 1) shows that whereas all three phenylalanine metabolites studied caused some redistribution, the overall effect was a reduction in the radioactivity of each fraction ( (Table 2) , although some redistribution was noted. Production of COz from glucose by isolated leucocytes was inhibited only by phenyl-lactate, which at a concentration of 10 mmol/l reduced production by 46%, and at 5 mmol/l by 33% (Table 2) .
Lymphocyte experiments
Phytohaemagglutinin stimulated twofold the total incorporation of [l-14C]acetate into the lipids of rabbit lymphocytes (Table 3 ). In the two experiments where lipid was chromatographed, a great increase in the percentage labelling of the cholesterol ester fraction was noted in the presence of phytohaemagglutinin (Table 4) . Only phenyl-lactate significantly affected acetate incorporation into the lipids of either resting or stimulated cells. This metabolite reduced acetate incorporation by 20% and 34% respectively Gable 3). The effect of phenyllactate on the distribution of acetate incorporation was similar to its effect on human leucocyte preparations, producing an overall reduction in the radioactivity of the major lipid fractions ( Table 4) . The incorporation of labelled phenylalanine and leucine into lymphocyte protein was stimulated 133 % and 212% respectively after 52 h in the presence of phytohaemagglutinin (Table 5) . Phenylalanine metabolites reduced the incorporation of both amino acids. Under conditions of active protein synthesis, phenylpyruvate was the most potent inhibitor, reducing phenylalanine incorporation by 57 % and leucine incorporation by 38 % (Table 5 ). The greater effect on phenylalanine incorporation may be due in part to dilution of the phenylalanine pool after transamination of the keto acid. In experiments with isolated human leucocytes, no inhibition of leucine incorporation was noted in the presence of phenyl- (61) 158+6 (73) 531 + 36 (78) loo+ 3 (80) 661 + 36 (79) 40+ 1 (80) 655+ 27 (34) pyruvate at the same concentration (10 mmol/l) used in the lymphocyte experiments. Phytohaemagglutinin stimulated tritiated uridine incorporation into lymphocyte RNA by a factor of 6.7 after 52 h. Phenylpyruvate inhibited incorporation in both resting and stimulated cells, by 42% and 52% respectively. Significant inhibition was also noted in the presence of phenyl-lactate and phenylacetate (Table 5) . After 3 days in the presence of phytohaemagglutinin, tritiated thymidine incorporation into lymphocytes was increased 38-fold. Reductions of up to 26 % were noted in resting cells in the presence of the compounds being investigated. DNA synthesis in the stimulated cell was potently inhibited by both phenyl-lactate and phenylpyruvate, which reduced thymidine incorporation to 10 % of control values ( Table 5) .
Enzyme studies
The effect of phenylalanine and its metabolites were studied on the activities of pyruvate kinase and citrate synthetase in rabbit lymphocytes. Phenylalanine and phenylpyruvate respectively are known to inhibit these enzymes from brain. A kinetic study of pyruvate kinase yielded a K,,, for phosphoenolpyruvate of 0.57 mmol/l and VmaX.
of 0.44 pmol min-' mg of supernatant protein-'. A Dixon plot of pyruvate kinase activity in the presence of phenylalanine showed that it was behaving as a competitive inhibitor with a Kl of 1.04 mmol/l. No inhibition was apparent in the presence of either phenylpyruvate or phenyl-lactate at concentrations up to 10 mmol/l. A study of citrate synthetase activity in a mitochondrial preparation showed a K,,, for acetyl-CoA of 5.1 pmol/l and V,,,,,. of 0.73 pmol min-' mg of mitochondrial protein-l. Phenylpyruvate inhibited the enzyme in a competitive manner (Dixon plot) with K1 7.3 mmol/l.:No inhibition was noted in the presence of either phenylalanine or phenyl-lactate at 10 mmol/l concentrations. Phenylalanine hydroxylase activity could not be demonstrated in human leucocytes nor in resting or phytohaemagglutininstimulated rabbit lymphocytes.
Discussion
Reduced incorporation of [14C]acetate into both myelin and non-myelin lipid of brains of hyperphenylalaninaemic rabbits has been demonstrated (Barbato et al., 1968) . In the hyperphenylalaninaemic suckling rat, Shah, Peterson & McKean (1970) showed that incorporation of [ '4C]glucose into cerebral lipids was reduced by 18 %. These workers also showed that phenylalanine was without effect on lipid synthesis in vitro, whereas phenylpyruvate and phenyl-lactate, at concentrations of 6 mmol/l, inhibited glucose incorporation into lipid by 18% and 32% respectively. Weber et al. (1970) found that 10 mmol/l phenylpyruvate inhibited glucose incorporation into lipid in foetal and adult rat brain slices by 54% and 33% respectively. In contrast, no reduction of acetate incorporation into cerebral lipid was noted in the acutely hyperphenylalaninaemic rat (Agrawal et al., 1970) .
In the present experiments phenylalanine and its metabolites were used at a concentration of 10 mmol/l. Phenylalanine itself was without effect on lipid synthesis. However, its metabolites, phenyl-lactate and phenylpyruvate, substantially reduced acetate incorporation into human leucocyte lipids ( Table  1) . They had no effect on glucose incorporation into lipid, but there was some re-distribution of label between polar lipid and triglyceride ; this probably reflects the different pathways of incorporation in leucocytes. These cells are incapable of glyconeogenesis (Stjernholm, Noble, Dimitrov, Morton & Falor, 1969) or fatty acid synthesis de nouo (Majerus & Lastra, 1967) . Glucose is incorporated into lipids predominantly as glycerol (Miras et al., 1967) whereas acetate is incorporated via mitochondria1 elongation of endogenous fatty acids (Miras, Mantzos & Levis, 1965 ; Ehrhart, Balachandran, Butkus, Lewis & Robertson, 1971) . Lymphocytes incorporate acetate in the same manner (Blomstrand, 1966) , though there is some evidence that phytohaemagglutinin-stimulated cells are capable of synthesis de nouo (Blomstrand & Liljeqvist, 1972) . The observations made in the present study are compatible with a decrease in fatty acid elongation. This inference is reinforced by the inhibition of CO, production in the presence of phenyl-lactate. Only about 4% of glucose utilized by the leucocyte is metabolized via the tricarboxylic acid cycle (Esmann, 1962) . Thus the observed decrease in CO, production reflects predominantly decreased pentose phosphatecycle activity. Reduced pentose cycle activity would lead to a lowered NADPHconcentration and possibly a reduction in fatty acid elongation and desaturation.
That this may be the case in phenylketonuria is suggested by the observation that the proportion, as well as the absolute amounts, of long-chain and unsaturated fatty acids are altered in myelin isolated from the brains of hyperphenylalaninaemic rats (Johnson & Shah, 1973) .
Reduced protein synthesis (Agrawal et a/., 1970) and altered amino acid pools (Richter & Wainer, 1971 ) have been demonstrated in the brain, but not the liver, of hyperphenylalaninaemic rats. Phenylpyruvate inhibits the incorporation of [3H]glucose into protein in foetal, but not adult, rat brain slices (Weber et al., 1970) . Most observations on protein synthesis in hyperphenylalaninaemia have been made in vivo and the effects may be due to metabolites of phenylalanine, as demonstrated here (Table 5 ) and in the foetal rat brain slice (Weber et al., 1970) . Phenylpyruvate can be formed from phenylalanine in the brain by phenylalanine aminotransferase (Benuck, Stern & Lajtha, 1971) . It inhibits the incorporation of [3H]glucose into RNA and DNA of foetal rat brain slices (Weber et al., 1970) . Castells, Zichka & Addo (1971) noted a decreased RNA content in the brains of adult rats fed with a phenylalanine-supplemented diet. Reduced amounts of DNA, RNA and protein in the brain of hyperphenylalaninaemic young rats have also been demonstrated (Prensky, Fishman & Daftari, 1974) . In the rabbit lymphocyte, phenylpyruvate and, to a lesser extent, the other metabolites reduced RNA synthesis, whereas phenylalanine itself was without effect (Table 5) . Similarly, phenylpyruvate and phenyl-lactate were potent inhibitors of DNA synthesis. Since DNA synthesis is the final step before mitosis, the observed inhibition might be the consequence of the reduced synthesis of other macromolecules. The observation of MacInnes & Schlesinger (1971) suggests that the inhibition in vivo, but not in vitro, of RNA synthesis may be secondary to decreased protein synthesis leading to reduced production of messenger RNA, or to decreased synthesis of some enzyme necessary for maintaining polyribosomal integrity. Weber et al. (1970) suggested that reduced glycolysis in the phenylketonuric brain might lead to reduced energy levels and consequently decreased synthesis of macromolecules.
Phenylpyruvate has been shown to inhibit a number of brain enzymes (Patel, 1972; Land & Clark, 1973) and phenylalanine inhibits pyruvate kinase from brain (Weber, 1969) and other tissues (Vijayvargiya, Schwark & Singhal, 1969) . In the present study, pyruvate kinase and citrate synthetase in rabbit lymphocytes were studied. Brain pyruvate kinase (Lowry & Passonneau, 1964 ) has a higher affinity for its substrate than the enzyme in other tissues. Also the K 1 for phenylalanine (8.5-1 1 mmol/l) (Weber, 1969 ) is higher than demonstrated here for the lymphocyte enzyme and elsewhere for other tissues (Vijayvargiya et a/., 1969) . Weber et a/.
(1970) concluded that reduced pyruvate kinase activity could lead to a decline in the production of ATP and other nucleotides vital in macromolecule synthesis. However, from a study of the amounts of glycolytic intermediates in the hyperphenylalaninaemic rat brain (Miller, Hawkins & Veech, 1973) , it was concluded that flux through pyruvate kinase may be maintained. In the hyperphenylalaninaemic chicken, no reduction in ATP level or energy charge was noted (Granett & Wells, 1972) . Land & Clark (1973) have demonstrated inhibition by phenylpyruvate of rat brain citrate synthetase, acetyl-CoA carboxylase and fatty acid synthetase. For citrate synthetase, these authors reported a K 1 of 0.7 mmol/l, in contrast to the value of 7.0 mmol/l observed here for the lymphocyte enzyme.
The incorporation experiments reported here compare with and lend further support to the results of investigations into this disease in brain and liver. The intracellular level of phenylalanine in granulocytes in classical and atypical phenylketonuria correlates well with the degree of the patients' disability (Andrews, McKeran, Watts, McPherson & Lax, 1973) . The leucocyte, and particularly the lymphocyte, are both easily available human cells and can provide a useful model to expand the study of metabolic disturbances produced by abnormal metabolites or drugs in other human tissues which cannot be obtained so readily because ethical considerations restrict their availability.
